AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in patients with Advanced Solid Malignancies

Trial Identifier:	D1532C00005
Sponsor:	AstraZeneca
NCTID::	NCT00463814
Start Date:	March 2007
Primary Completion Date:	June 2008
Study Completion Date:	December 2023
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Dutch Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Sutton, GB, SM2 5PT
NL	Nijmegen, NL, 6525 GA
NL	UTRECHT, NL, 3584 CX
US, CO	Aurora, CO, US, 80045

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.